Australian scientists have made a breakthrough when it comes to the future of Alzheimer’s diagnosis.
It has been discovered that a combination of iron reducing drugs after early brain scans could effectively lead to reducing the symptoms of dementia with researchers finding that high levels of brain iron in patients is connected to cognitive decline.
Research has shown that patients suffering from Alzheimer’s have high levels of iron and amyloid resulting in short term memory loss, difficulty with language and executive function. Patients with low levels of brain iron who were also tested proved to have a much slower decline.
Based on these findings, it is hoped that trials will commence in Australia later this year and then lead to the start of an updated 60 year old health check, including a brain iron scan and drug therapy.